Navellier & Associates Inc Abiomed Inc Transaction History

Navellier & Associates Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$159.31 - $223.54 $180,179 - $252,823	-1,131 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$175.89 - $279.23 $1,758 - $2,792	10 Added 0.89%	1,131 $201,000
Q2 2019 Jul 17, 2019	SELL	$250.96 - $284.94 $6.54 Million - $7.42 Million	-26,042 Reduced 95.87%	1,121 $292,000
Q1 2019 May 15, 2019	BUY	$276.39 - $362.25 $997,491 - $1.31 Million	3,609 Added 15.32%	27,163 $7.76 Million
Q4 2018 Jan 15, 2019	BUY	$281.08 - $444.25 $323,242 - $510,887	1,150 Added 5.13%	23,554 $7.66 Million
Q3 2018 Nov 14, 2018	BUY	$354.53 - $449.75 $195,346 - $247,812	551 Added 2.52%	22,404 $10.1 Million
Q2 2018 Aug 06, 2018	BUY	$278.07 - $446.21 $3.06 Million - $4.91 Million	11,000 Added 101.35%	21,853 $8.94 Million
Q1 2018 May 21, 2018	BUY	$192.49 - $295.85 $250,237 - $384,605	1,300 Added 13.61%	10,853 $3.16 Million
Q4 2017 Feb 12, 2018	BUY	$168.78 - $199.74 $895,377 - $1.06 Million	5,305 Added 124.88%	9,553 $1.79 Million
Q3 2017 Nov 14, 2017	SELL	$145.39 - $168.6 $138,556 - $160,675	-953 Reduced 18.32%	4,248 $716,000
Q2 2017 Aug 24, 2017	BUY	N/A	5,201	5,201 $745,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.